Hopkinton life sciences manufacturer Lykan Bioscience has named Keith McCormick as the company’s new CFO.
McCormick brings 20 years of experience working in hi-tech organizations in Scotland, Switzerland, Germany, and the U.S., according to a release from Lykan. Most recently, he spent 18 months consulting with emerging biotechnology companies as they scaled up operations. Prior to that, he spent six years with Patheon Pharmaceuticals of North Carolina as vice president of finance.
Lykan Bioscience is a privately held cell-based therapies contract manufacturing services organization. Last year it unveiled its new manufacturing facility anticipated to create 125 jobs.
